Investor Presentation
AI summary
- Consolidated Q1 FY27 revenue at ₹16,076 crs, +25% YoY; EBITDA ₹991 crs, +105% YoY, margin 6.4% (+260 bps)
- PBT before minority interest ₹869 crs, +137% YoY; PAT pre-NCI ₹718 crs, +156% YoY, margin 4.6% (+240 bps)
- Adjusted Q1 FY27 revenue ₹15,557 crs, +21% YoY; EBITDA ₹472 crs, -2% YoY, margin 3.0% (-80 bps)
- Mobile & Other EMS division revenue +22% YoY; Consumer Electronics & Appliances revenue +21% YoY
- ROCE at 34.1%, down 1070 bps from FY26; ROE at 23.4%, down 470 bps
- Net working capital days at -5, improved by 3 days vs FY26
- Free cash flow negative ₹676 crs in Q1 FY27
- Board approved re-appointment of Whole Time Director and Managing Director for 5 years from May 2027
- Grant of 4,000 stock options under ESOP 2023 approved for employees
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 DIXON — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add DIXON to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Dixon Technologies (India) Limited
Important.
The summary above is generated automatically from Dixon Technologies (India) Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.